ReviewJournal of clinical medicine2021

Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge.

Alessandra Iurlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.